NO985414L - Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt - Google Patents

Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt

Info

Publication number
NO985414L
NO985414L NO985414A NO985414A NO985414L NO 985414 L NO985414 L NO 985414L NO 985414 A NO985414 A NO 985414A NO 985414 A NO985414 A NO 985414A NO 985414 L NO985414 L NO 985414L
Authority
NO
Norway
Prior art keywords
sodium
salt
containing potassium
pharmaceutical
trioxaprozin
Prior art date
Application number
NO985414A
Other languages
English (en)
Norwegian (no)
Other versions
NO985414D0 (no
Inventor
Mark E Adams
Subhash Desai
Aziz Karim
Kalidas Paul
Douglas J Schaaf
David J Zold
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO985414D0 publication Critical patent/NO985414D0/no
Publication of NO985414L publication Critical patent/NO985414L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NO985414A 1996-05-20 1998-11-20 Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt NO985414L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1903396P 1996-05-20 1996-05-20
PCT/US1997/007637 WO1997044022A1 (fr) 1996-05-20 1997-05-14 Formulations pharmaceutiques contenant du potassium, du sodium et des sels tris d'oxaprozine

Publications (2)

Publication Number Publication Date
NO985414D0 NO985414D0 (no) 1998-11-20
NO985414L true NO985414L (no) 1999-01-19

Family

ID=21791076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985414A NO985414L (no) 1996-05-20 1998-11-20 Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt

Country Status (20)

Country Link
US (1) US6030643A (fr)
EP (1) EP0901372B1 (fr)
JP (1) JP4185974B2 (fr)
KR (1) KR20000015865A (fr)
CN (1) CN1129429C (fr)
AT (1) ATE299699T1 (fr)
AU (1) AU718030B2 (fr)
BR (1) BR9710448A (fr)
CA (1) CA2255064C (fr)
CZ (1) CZ370298A3 (fr)
DE (1) DE69733752T2 (fr)
ES (1) ES2248850T3 (fr)
IL (1) IL126998A (fr)
NO (1) NO985414L (fr)
NZ (1) NZ332861A (fr)
PL (1) PL330145A1 (fr)
RU (1) RU2197244C2 (fr)
TW (1) TW586929B (fr)
WO (1) WO1997044022A1 (fr)
ZA (1) ZA974366B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE365541T1 (de) * 1999-09-29 2007-07-15 Scherer Technologies Inc R P Granulate von arzneistoffsalzen mit hydrolisierter cellulose
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
FR2828810B1 (fr) * 2001-08-27 2005-10-07 Lvmh Rech Composition cosmetique a effet tenseur contenant un polymere d'origine naturelle et un agent hydratant polyhydroxyle
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
PE20061303A1 (es) * 2005-03-30 2006-12-07 Astion Dev As Composicion farmaceutica que comprende oxaprozina
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
EP1888056A4 (fr) * 2005-06-01 2008-09-03 Teva Pharma Utilisation du ladostigil pour traiter la sclerose en plaques
EP2124901B1 (fr) 2007-02-01 2017-07-19 Takeda Pharmaceutical Company Limited Préparation de comprimé ne provoquant pas de problème de pastillage
SG11201405353VA (en) * 2012-03-22 2014-09-26 Transtech Pharma Llc Tris(hydroxymethyl)aminomethane salts of a small-molecule glp1r agonist and pharmaceutical compositions and uses thereof
EP3275433A1 (fr) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Composition à libération prolongée comprenant du tolcapone micronisé

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4190584A (en) * 1976-08-13 1980-02-26 John Wyeth & Brother Limited Process for preparing oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
GB2097389B (en) * 1981-04-28 1984-11-28 Wyeth John & Brother Ltd Oxazole derivative
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions
US4599359A (en) * 1982-12-09 1986-07-08 Stephen A. Cooper Hydroxyzine-containing analgesic combinations
GB8329326D0 (en) * 1983-11-03 1983-12-07 Wyeth John & Brother Ltd Oxazole derivatives
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
WO1992007561A1 (fr) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Preparation d'un gel anti-inflammatoire et analgesique
CA2170488A1 (fr) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions renfermant un sel d'acide propionique d'amino-acide, agent anti-inflammatoire non steroidique et au moins un decongestionnant, un expectorant un antihistaminique et un antitussif
WO1995007079A1 (fr) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine

Also Published As

Publication number Publication date
JP2001503734A (ja) 2001-03-21
CA2255064A1 (fr) 1997-11-27
IL126998A0 (en) 1999-09-22
EP0901372B1 (fr) 2005-07-20
AU3059797A (en) 1997-12-09
KR20000015865A (ko) 2000-03-15
CN1129429C (zh) 2003-12-03
ATE299699T1 (de) 2005-08-15
CN1225580A (zh) 1999-08-11
AU718030B2 (en) 2000-04-06
CA2255064C (fr) 2006-10-10
CZ370298A3 (cs) 1999-05-12
NO985414D0 (no) 1998-11-20
RU2197244C2 (ru) 2003-01-27
PL330145A1 (en) 1999-04-26
DE69733752T2 (de) 2006-06-01
NZ332861A (en) 2000-08-25
TW586929B (en) 2004-05-11
IL126998A (en) 2003-12-10
ES2248850T3 (es) 2006-03-16
US6030643A (en) 2000-02-29
ZA974366B (en) 1998-05-20
WO1997044022A1 (fr) 1997-11-27
JP4185974B2 (ja) 2008-11-26
BR9710448A (pt) 1999-08-17
DE69733752D1 (de) 2005-08-25
EP0901372A1 (fr) 1999-03-17

Similar Documents

Publication Publication Date Title
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
EE04111B1 (et) Raku adhesiooni inhibiitorid, nende kasutamine janeid sisaldavad farmatseutilised kompositsioonid
ATE245977T1 (de) Therapeutische substituierte guanidine
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
IL218087A0 (en) Anti-ngf antibodies, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments for the treatment of pain
BR0313059B8 (pt) composto, e, composição farmacêutica
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
EA200100337A1 (ru) Стабильные жидкие составы ботулинического токсина
SG124234A1 (en) Cell adhesion inhibitors
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
DE69905170T2 (de) Thiazolopyrimidinderivate
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
NO985414L (no) Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt
YU13301A (sh) Muskarinski agonisti i antagonisti
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
SE9802937D0 (sv) Novel compounds
NZ330944A (en) Peptide derivatives
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
AU9731198A (en) Histogranin peptide and their analgesic use
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
PT934342E (pt) Composicao contendo quitosano

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application